Related Experiment Video
Updated: Apr 14, 2026
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Strategies to relieve immunosuppression in pancreatic cancer
Max Schnurr1, Peter Duewell, Christian Bauer
1Division of Clinical Pharmacology & Center for Integrated Protein Science Munich (CIPSM), Klinikum der Universität München, Munich, Germany.
Abstract:
Despite continuous progress in the understanding of deregulated pathways in pancreatic cancer cells and development of targeted therapies, therapeutic advances with clinical benefit have been scarce over the last decades. The recent success of immunotherapy for some solid cancers has fueled optimism that this approach might also work for pancreatic cancer. However, a highly immunosuppressive microenvironment mediated by tumor, stromal and immune cells creates a major hurdle for immunotherapy. Mouse models have helped to unravel critical immunosuppressive mechanisms that could serve as novel therapeutic targets. Here we review new promising strategies that alone or in combination with other modalities, such as chemotherapy or irradiation, have the potential to lead to tumor immune control and finally better clinical outcome.
Insights
Pancreatic cancer immunotherapy faces challenges from a suppressive tumor microenvironment. Novel strategies targeting these immunosuppressive mechanisms show promise for improving treatment outcomes.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Pancreatic cancer has seen limited therapeutic advances despite progress in understanding deregulated pathways.
- Immunotherapy offers potential but faces significant hurdles due to the tumor's immunosuppressive microenvironment.
Purpose of the Study:
- To review novel strategies for overcoming immunosuppression in pancreatic cancer.
- To explore therapeutic approaches that could lead to tumor immune control.
Main Methods:
- Review of current research on pancreatic cancer and immunotherapy.
- Analysis of immunosuppressive mechanisms identified in mouse models.
- Evaluation of combination therapies including chemotherapy and irradiation.
Main Results:
- The tumor microenvironment in pancreatic cancer is highly immunosuppressive, hindering immunotherapy efficacy.
- Mouse models have identified key immunosuppressive mechanisms.
- Promising strategies are emerging to target these mechanisms.
Conclusions:
- Targeting the immunosuppressive tumor microenvironment is crucial for effective pancreatic cancer immunotherapy.
- Combination strategies hold potential for improved clinical outcomes in pancreatic cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...